Computer-generated “synthetic contingency” plans at times of logistics and supply problems: scenarios for hydroxychloroquine and remdesivir

Abstract

A computer program for retrosynthetic planning helps develop multiple “synthetic contingency” plans for hydroxychloroquine and also routes leading to remdesivir, both promising but yet unproven medications against COVID-19.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2020
Source ID
10.1039/d0sc01799j

Entities

People

  • Agnieszka Wołos
  • Bartosz Andrzej Grzybowski
  • Ewa P. Gajewska
  • Karol Molga
  • Martyna Moskal
  • Piotr Dittwald
  • Rafal Roszak
  • Sara Szymkuć
  • Wiktor Beker

Organizations

  • Center for Soft and Living Matter
  • Defense Advanced Research Projects Agency
  • Institute for Basic Science
  • Institute of Organic Chemistry
  • National Science Centre Poland
  • Polish Academy of Sciences

Tags

Readers

  • Immunology and Pathology
  • Infectious Disease/Epidemiology
  • Systems Analysis and Design